Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron

Published:2024-06 Issue:6 Volume:88 Page:106165
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Paternina-Caicedo Angel^ORCID,Quevedo David Santiago,Ríos Diana Sofía,Moyano Diane,Alvis-Guzmán Nelson,Alviz-Zakzuk Nelson Rafael,Salcedo Fernando,Ramírez-Suarez Javier^ORCID,Smith Adrian D.,De la Hoz-Restrepo Fernando^ORCID

Publisher

Elsevier BV

Reference8 articles.

1. Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis;Au;BMJ,2022

2. Ministry of Health. Vacunación contra COVID-19; 2023. 〈https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx〉 [Accessed April 2, 2023].

3. Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses;Andersson;BMJ,2023

4. Effectiveness of homologous and heterologous Covid-19 boosters against Omicron;Accorsi;N Engl J Med,2022

5. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil;Cerqueira-Silva;Nat Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP